Last reviewed: July 8, 2026

Last updated: July 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injection works by slowing stomach emptying and increasing fullness signals to your brain—effects most patients notice within the first few days. If you're starting this medication through PlexusDx, knowing what to expect during your first month helps you manage the transition smoothly and recognize when changes are normal versus when to reach out to your care team.

Start your GLP-1 program with PlexusDx

One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.

Start your intake →

How Semaglutide Affects Your Body in Week One

During your first injection, semaglutide begins activating GLP-1 receptors in your digestive system and brain. Most patients report a noticeable decrease in appetite within 24 to 72 hours, often describing it as feeling satisfied after smaller meals. Your first week is primarily about your body acclimating to the medication—you may feel different energy levels, and some people notice their relationship with food shifting almost immediately.

The medication reaches peak concentration in your bloodstream around 1 to 3 days after injection. During this window, appetite suppression is typically strongest, which is why many patients find it easier to stick to their meal plan early in the week. This natural reduction in hunger is the primary mechanism driving weight loss—not stimulation or restriction, but genuine physiological change.

Common First-Month Side Effects and How Long They Last

Nausea affects roughly 30 to 50 percent of patients starting semaglutide, but it's usually mild and temporary. Most people experience this only in the first 1 to 2 weeks, with symptoms improving significantly by week three as your body adjusts. Taking your injection in the evening, eating smaller portions, and staying hydrated can help minimize nausea—these practical adjustments address the symptom without requiring medication changes.

Other common first-month experiences include mild constipation, reduced appetite for foods you normally enjoy, and occasional fatigue as your body adapts to eating less. These effects are signs the medication is working, not indicators of a problem. By week four, most patients report feeling normalized and comfortable with their new baseline. If side effects persist or worsen beyond the first month, your PlexusDx care team can assess whether dose timing adjustments or lifestyle modifications would help.

Managing Your First Semaglutide Injection Timing and Technique

PlexusDx provides clear guidance on injection site rotation—the abdomen, thigh, or upper arm are all appropriate areas that rotate to prevent tissue irritation. Your first injection sets the pattern for all future doses, so choosing a consistent day of the week (many patients prefer Sunday evening) helps establish a reliable routine. The injection itself takes less than ten seconds and causes minimal discomfort since the needle is very fine.

Timing your injection in relation to meals influences your comfort level during the first week. Injecting in the evening allows any initial nausea to occur while you're winding down rather than during your workday. Some patients keep a small notepad to track when they inject, how they feel, and what meals worked best—this simple log becomes invaluable information for your PlexusDx provider if any adjustments are needed in month two.

Nutrition and Eating Patterns During Your First Month

Your appetite will change, but your nutritional needs don't. The first month is an ideal time to shift toward nutrient-dense foods—lean proteins, non-starchy vegetables, and healthy fats—because semaglutide naturally makes overeating much less appealing. Protein becomes particularly important since smaller portion sizes mean every bite needs to work harder nutritionally. Aiming for 80 to 100 grams of protein daily helps preserve muscle mass while your body adapts.

Many patients accidentally under-eat during their first week because the appetite suppression is powerful. Eating when you're not hungry feels counterintuitive, but meeting your basic calorie and nutrient needs supports sustained energy and prevents your metabolism from slowing. This is where the PlexusDx Precision Peptide Genetic Test becomes valuable in month two—your genetic insights reveal how your specific peptide pathways respond to nutrition, helping your care team personalize your eating strategy beyond your first month.

When to Contact Your PlexusDx Care Team During Month One

Mild nausea, reduced appetite, and slight fatigue are expected and typically resolve on their own. However, persistent vomiting, severe abdominal pain, rapid heartbeat, or signs of dehydration warrant immediate communication with your PlexusDx provider. These symptoms are rare but should never be ignored—your care team can determine whether they reflect normal adjustment or require intervention.

PlexusDx makes follow-up simple: you can message your care coordinator through the patient portal if questions arise during your first month. Many practices encourage a check-in around day 10 to assess how you're tolerating the medication and whether any practical adjustments would improve your comfort. This proactive communication often prevents small concerns from becoming barriers to your treatment success.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How quickly will I see weight loss results after my first semaglutide injection?

Most patients notice appetite reduction within 2 to 3 days, but meaningful weight loss typically becomes measurable after 2 to 4 weeks as you consistently consume fewer calories. Initial weight changes often reflect reduced water retention and food volume rather than fat loss. PlexusDx recommends weighing yourself weekly after the first month to track trends rather than focusing on daily fluctuations.

Will I feel hungry at all during my first month on semaglutide?

Hunger typically diminishes significantly but may not disappear completely, especially in your first week before steady-state medication levels are reached. You'll likely notice the absence of cravings more than the absence of physical hunger—that distinction is important. By week three, most patients report eating primarily out of routine rather than actual hunger, making meal planning much more straightforward.

How much does semaglutide injection cost at PlexusDx, and will my price increase if my dose increases?

PlexusDx Compounded Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan), with your dose optimized over time based on your response and goals. Your dose may need to go up—your price won't. PlexusDx medications are HSA/FSA eligible and available in all 50 states without insurance requirements or membership fees.

Is compounded semaglutide from PlexusDx the same as brand-name Ozempic?

PlexusDx compounded semaglutide contains the same active ingredient as Ozempic but is prepared by licensed 503A compounding pharmacies to your specific needs. While not FDA-approved as a finished product, compounded medications follow strict quality and sterility standards. Many patients find the personalized dosing and lower cost through PlexusDx advantageous compared to brand options.

How does the PlexusDx Precision Peptide Genetic Test help during my first month?

The Precision Peptide Genetic Test ($298) analyzes 14 peptide pathways including GIPR, and MC4R variants to reveal your unique metabolic predispositions. This genetic insight helps your PlexusDx care team refine your nutrition strategy and medication approach starting in month two, moving beyond first-month adjustment into truly personalized optimization.

Related Reading

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves